INTERNATIONAL PATENT: HANX BIOPHARMACEUTICALS, (WUHAN) LTD. FILES APPLICATION FOR "NKG2A/CD94-TARGETING ANTIBODIES AND USES THEREOF"

GENEVA, Aug. 17 -- HANX BIOPHARMACEUTICALS, (WUHAN) LTD. (Building A8, Bio Park II, Jiufeng Yi Road, Hongshan DistrictWuhan, Hubei 430073) filed a patent application (PCT/CN2025/076215) for "NKG2A/CD94-TARGETING ANTIBODIES AND USES THEREOF" on Feb 07, 2025. With publication no. WO/2025/168052, the details related to the patent application was published on Aug 14, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KE, Hang (Building A8, Bio Park II, Jiufeng Yi Road, Hongshan DistrictWuhan, Hubei 430073), ZHANG, Faming (Building A8, Bio Park II, Jiufeng Yi Road, Hongshan DistrictWuhan, Hubei 4300...